Financing - August 26, 2019
Altimmune announces $3.7 Million in Additional BARDA Funding
The Biomedical Advanced Research and Development Authority (BARDA) is modifying its existing anthrax vaccine development contract with Altimmune by awarding an additional $3.7 million. The increase in funding is primarily directed toward a Phase 1b clinical trial of NasoShield to evaluate alternative methods of intranasal dosing in humans. Phae Ib trial expected to start 2019 […]
Financing - August 13, 2019
InfiCure Bio receives additional funding
The company has received additional funding from NLC InfiCure Bio and Partnerinvest Övre Norrland. The funding will be used to speed up the validation of additional indications in the NIF mouse, states the company. “This is a golden opportunity to broaden our customer base and increase the revenue of the company,” it says in its […]
Financing - August 2, 2019
EUR 5 million investment in Forendo Pharma
Sunstone Life Science Ventures makes a €5 million investment into the Finnish women’s health company Forendo Pharma to finance clinical studies in endometriosis. Sunstone has announced its first investment out of its Life Science Ventures Fund IV into Forendo Pharma, a Finnish clinical stage drug development company focusing on novel treatments in women’s health. The […]
Financing - August 2, 2019
Aqilion receives SEK 100 million through conversion of outstanding warrants
In March of 2018, Aqilion AB (formerly Partners för Utvecklingsinvesteringar inom Life Sciences, P.U.L.S. AB) carried out a directed issue of units. Each unit consisted of one share and two warrants. At that time, Aqilion raised SEK 100 million through subscription for shares. All outstanding warrants have now been converted to shares, which raised an […]
Financing - June 27, 2019
Nexstim receives funding from Wings for Life Foundation
The Helsinki University Hospital in Finland has received significant funding from the renowned Wings for Life Foundation to continue its research into spinal cord injury rehabilitation using Nexstim’s SmartFocus technology. Wings for Life specifically supports international research focused on finding new treatment methods for spinal cord injury patients whose rehabilitation is known to be highly […]
Business article - June 27, 2019
Coala Life raises SEK 11 million
The Swedish company has won the backing of the investment company Blue, which has placed an additional SEK 10 million investment (together with investments from the executives at the company) in the company following an earlier round of SEK93 million announced in April this year. The capital intake from Blue will enable Coala Life to […]
